WEST PALM BEACH, Fla.--(BUSINESS WIRE)--Rennova Health, Inc. (NASDAQ:RNVA) (NASDAQ:RNVAZ), a vertically integrated provider of industry-leading diagnostics and supportive software (“Rennova” or the “Company”), reports financial results for the three and six months ended June 30, 2016, and provides a business update.
Business highlights for the second quarter of 2016 and recent weeks include:
Converted approximately $2.0 million of liabilities into equity in August 2016
Business highlights for the second quarter of 2016 and recent weeks include:
Converted approximately $2.0 million of liabilities into equity in August 2016
